Back to results
US 2014/0275094 A1Published application
Method for treating pulmonary arterial hypertension in a patient not having idiopathic pulmonary fibrosis
AssigneeGilead Sciences, Inc.
InventorsHunter Campbell Gillies, Tobias Peschel, David J. Pizzuti
Life of this patent
Estimating the term…
Abstract
There is provided a method of treating pulmonary hypertension in a patient in need thereof, said method comprising: administering a therapeutically effective amount of ambrisentan to the patient with pulmonary arterial hypertension, wherein the patient has been determined not to have idiopathic pulmonary fibrosis.
Claims21
A method of treating pulmonary hypertension in a patient in need thereof, said method comprising:
- administering a therapeutically effective amount of ambrisentan to the patient with pulmonary arterial hypertension;
- wherein the patient has been determined not to have idiopathic pulmonary fibrosis.
A method of treating pulmonary arterial hypertension in a patient in need thereof, comprising:
- administering a therapeutically effective amount of ambrisentan to the patient with pulmonary arterial hypertension;
- wherein the patient has been determined not to have idiopathic pulmonary fibrosis, and
- wherein the method is carried out without drug labeling instruction to monitor one or more biomarkers of liver function during ambrisentan treatment.
-29. (canceled)
Dependencies are inferred from the claim text.